Galleri test follow-up study
This study looks at the Galleri test, a blood test that checks for early signs of cancer. If you already had the Galleri test as part of your regular care, this study will collect some information from your medical records to learn more about how the test works in the real world.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have already had the Galleri blood test ordered by your doctor as part of your normal medical care.
- You are able to sign legal forms to allow the study to use your medical information.
- You are not a GRAIL employee or contractor.
- You did not have the Galleri test as part of a previous research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a blood test called Galleri (and also how it compares when people have not yet had it) works for older adults with Medicare. It may help find whether the test can improve cancer detection or follow-up for people who are not already in urgent cancer workups.
This study tests a new way to find cancer early in adults who have signs or symptoms that might be cancer. It may help people get diagnosed sooner and start treatment faster.
This trial is testing a blood test that looks for early signs of multiple types of cancer. It is designed for current or former military members who are at least 45 years old and have used VA healthcare. If the test finds something, you would need to be willing to travel to Boston for follow-up.
This study looks for early signs of ovarian cancer in a simple blood test. It may help people with BRCA gene changes catch problems sooner, before or after preventive surgery.
This study tests a blood-based multi-cancer early detection (MCED) screening test in people with a high risk of cancer due to inherited gene changes or strong family history. The goal is to see if this test can find cancer early.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
Hear when a new Data Collection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.